Improving Maternal Cardiovascular Outcomes Through the Implementation of a Hypertensive Disorders of Pregnancy Bundle in Nigeria

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
AgeNot listed
SponsorWashington University School of Medicine

About this trial

The goal of this interventional study is to learn from patients and healthcare providers at 4 health institutions (study sites) in Abuja and Kano in Nigeria what ways to best develop the content of a Hypertensive Disorders of Pregnancy ( HDP) Management package for pregnant women, and evaluate the effectiveness of implementing this package in improving cardiovascular health of pregnant women. The main question it aims to answer is:

Will a contextualized home BP monitoring program lead to better BP control among patients with HDP in Nigeria?

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Postpartum adults (>18 years)

postpartum emancipated minors (in accordance with the Nigerian guidelines for young persons' participation in research and reproductive health services)

with diagnosis of HDP prior to delivery delivered at one of the participating sites able to provide informed consent.

Disqualifiers

unable to provide consent.

Trial design

Design model

Crossover

Treatments tested in this trial

  • Hypertension Disorders of Pregnancy (HDP) Implementation Bundle

    Other intervention

    The HDP Implementation Bundle will consist of 4 main blocks namely; patient education, home BP monitoring, a contextualized follow-up protocol and provision of free anti-hypertensives if need. Collectively, these will lead to design and development of a contextualized home BP monitoring program.

Treatment groups

1,200 Participants
are divided into 2 treatment groups
Group A: Control Phase: For capturing baseline parameters.No intervention 0 interventions
Group B: Intervention Phase: Participants will crossover to the intervention phase after 12 months.Experimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Between group difference in change in systolic BP from baseline to 6-week follow-up

The change in systolic BP from baseline to 6-week follow-up between the intervention and control group

Time frame
Baseline to 6 weeks

Secondary outcomes

1

Between group differences in change in diastolic BP at 6 weeks follow-up and change in both systolic an diastolic BP at 12 weeks

The change in diastolic BP from baseline to 6-week follow-up between the intervention and control groups.

Time frame
Baseline to 6(and 12) weeks
2

Between group differences in systolic and diastolic BP at 12 weeks follow-up

The change mean systolic and diastolic BPs 12 weeks follow-up between the intervention and control group

Time frame
Baseline to 12 weeks

Other outcomes

1

Incidence of serious adverse events (eg dizziness) [Safety Outcomes]

Safety outcomes include incidence of serious adverse events (eg dizziness) collected via surveys and patient charts at 6- weeks,12-weeks and 6-months postpartum

Time frame
Baseline to 6 months
2

Number of eligible patient participants who utilized the HDP Implementation Bundle (Reach)

Number, age, socio-demographics of patients who were enrolled in the HDP Implementation Bundle.

Time frame
Baseline up to 57 months
3

Between-group difference in change in systolic BP from baseline to 6-week follow-up (Effectiveness)

Did the HDP Implementation Bundle impact effectiveness outcomes?

Time frame
Baseline up to 6 weeks
4

Number of clinical sites where the HDP Implementation Bundle was widely utilized (Adoption)

Records and surveys assessed to establish whether the HDP Implementation Bundle was widely utilized at clinical sites. Patient enrolment in HDP Bundle, where at least 1 home BP measurement is reported among total participants.

Time frame
Baseline up to 57 months

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Washington University School of Medicine

Lead sponsor

National Heart, Lung, and Blood Institute (NHLBI)

Collaborator